190 likes | 211 Views
Explore research on implementing best practices for co-occurring disorders, featuring studies from leading institutions and insights on access to integrated services.
E N D
Access to Best Practices for Co-Occurring Disorders: Research and Practice Partnerships Constance Weisner, DrPH, MSWStacy Sterling, MSW, MPHSujaya Parthasarathy, PhDJennifer Mertens, MACharlie Moore, MD, MBA University of California at San Francisco and Division of Research, Northern California Kaiser PermanenteConference on “Complexities of Co-Occurring Conditions: Harnessing Services Research to Improve Care for Mental Health, Substance Use, and Medical/Physical Disorders,” June 24, 2004, Washington, DC From studies funded by the National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, Center for Substance Abuse Treatment, and Robert Wood Johnson Foundation
Broadening the research focus in improving access and utilization of best practices • Asking new research questions • develop questions in collaboration with clinicians • Studying the implementation process • the variety of stakeholders that influence adoption of, and access to, best practices
Sources of Research Questions • Research literature • Policy issues • Clinical concerns Generates research intervention study Intervention evaluated • Health Plan • Clinicians • Program (CD & MH) • Primary Care • Consumers • Purchasers/employers • Accreditation bodies • Health policy Program change implemented Stakeholder concerns shape implementation Sterling & Weisner, (2002) “Closing the Loop: A Model to Address the Transfer of Research to Practice”
OVERVIEW • Importance of access Screening, assessment, and integrated services • Conceptual model and application
Research Supporting Integrated Services • Assessment:Many individuals entering CD and MH treatment have co-occurring problems.(Rounds-Bryant et al., Grella et al. 2001; Rao, 2000; Greenbaum et al., 1996) • Screening:These co-occurring problems could be identified earlier before they are severe.(Samet et al., 2001) • Integrating services:Providing services that address those problems is related to outcomes.(McLellan et al., 1998, 1993; Willenbring & Olson, 1999)
Setting Kaiser Permanente Medical Care Programof Northern California • Sacramento • Non-profit, group practice prepaid HMO • 3.2 million members (35% of commercially insured population) • “Carved-in” psychiatry and chemical dependency services • Vacaville • Vallejo • Oakland
Adolescent Chemical Dependency Treatment Sample • 419 adolescents (143 girls, 276 boys) and parents • 4 facilities • Age ranged from 13 to 18 years • Ethnicity: 9% Native American/Asian 16% African-American 20% Hispanic 49% White • Treatment intake, 6-month, and 1-, 3-, & 5 years • Response rate: 6-month 91.4%; 1-year 92.1%
Psychiatric Conditions of Adolescents Entering CD Treatment (in %)
Role of Dual Treatment: Logistic Regression Predicting Abstinence at 6 Months Receiving mental health services while in chemical dependency services was related to better alcohol and drug outcomes at 6 months.
An Adult Example: 5-Year Abstinence when Psychiatric Services Provided For those who still had psychiatric problems at 12 month follow-up: 2 or more hours/year over the 5 years O.R. = 5.5* *P<.05 Controlling for age, gender, type of dependence, abstinence goal, readmission, # of 12-step meetings, recovery-oriented social support, treatment intensity
An Adult Example: CD Patients and Matched Health Plan Members: Medical Conditions* *all p<.001 Mertens, Lu, Parthasarathy, Moore, Weisner. (2003). Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: Comparison to matched controls. Archives of Internal Medicine.
Randomized Adult SAMC Group: Logistic Regression Predicting Abstinence at 6 Months: Controlling for baseline alcohol and drug severity Weisner C, Mertens J, Parthsarathy S, Moore C, Lu Y. (2001). Integrating primary medical care with addiction treatment: A randomized controlled trial. JAMA 286(14):1715-1723.
Medical Costs 12 Months after Treatment for Randomized CD Patients with Psychiatric & Medical Conditions *p<.05; **p<.01 Parthasarathy S, Mertens J, Moore C, Weisner C. (2003). The utilization and cost impact of integrating substance abuse treatment and primary care. Medical Care.
Sources of Research Questions • Research literature • Policy issues • Clinical concerns Generates research intervention study Intervention evaluated • Health Plan • Clinicians • Program (CD & MH) • Primary Care • Consumers • Purchasers/employers • Accreditation bodies • Health policy Program change implemented Stakeholder concerns shape implementation Sterling & Weisner, (2002)“Closing the Loop: A Model to Address the Transfer of Research to Practice”
Research Practice Model CD & MH Directors’/Chiefs’ Groups: • Business case: outcomes & cost • Parity legislation • Identifying next generation of research questions • Survey of pediatricians Clinicians • Development of assessment for MH and CD clinics • PC & ER physicians • Results to their professional organizations • Identifying next generation of research questions • Assessment in MH and CD clinics • Readiness to change AOD use in MH clinics Dual Diagnosis Best Practice Committee • Concept & development of liaison model • Core competencies, care guidelines • Training • Identifying next generation of research questions • Dual diagnosis continuity of care, utilization & cost
Conclusions • A wide variety of stakeholders influence access • Demonstrating both outcome and cost is important in improving access • Integrating research and practice can lead to better understanding how to study and address access
Felicia Chi, MPH Steve Allen, PhD David Pating, MD Bill Brostoff, MD Christine Waters, MD Agatha Hinman, BA Georgina Berrios, BA Tom Ray, M.A. Wendy Lu, MPH Cynthia Campbell, PhD Derek Satre, PhD Carolynn Kohn, PhD Melanie Jackson, BA Cynthia Perry-Baker, BA Lynda Tish, BA Barbara Picchoto, BA Kaiser Permanente Clinics Oakland Sacramento San Francisco Stockton Vacaville Vallejo COLLABORATORS